Relevant bibliographies by topics / Pharmaceutical and biotechnology industries

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Pharmaceutical and biotechnology industries'

Author: Grafiati
Published: 4 June 2021
Last updated: 11 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmaceutical and biotechnology industries.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmaceutical and biotechnology industries"

1

Chiu, Robert I. T. "Biotechnology in Taiwan." Asia-Pacific Biotech News 06, no. 20 (2002): 730–34. http://dx.doi.org/10.1142/s0219030302001556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Goldman, Michael, Georgia Evans, and Andrew Zappia. "Inherent Anticipation in the Pharmaceutical and Biotechnology Industries." Cold Spring Harbor Perspectives in Medicine 5, no. 8 (2015): a021006. http://dx.doi.org/10.1101/cshperspect.a021006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Aronson, Debra, Simon G. Best, Michael J. Werner, and Walter H. Moos. "Ethical Issues in the Biotechnology and Pharmaceutical Industries." Drug Development Research 63, no. 3 (2004): 89–92. http://dx.doi.org/10.1002/ddr.10403.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ganem, Don. "Physician-Scientist Careers in the Biotechnology and Pharmaceutical Industries." Journal of Infectious Diseases 218, suppl_1 (2018): S20—S24. http://dx.doi.org/10.1093/infdis/jiy308.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nunnally, Allen C., Christopher J. Webster, Scott A. Brown, and Gary A. Cohen. "Genetic Patent Protection in the Pharmaceutical and Biotechnology Industries." Public Health Genomics 8, no. 4 (2005): 209–16. http://dx.doi.org/10.1159/000087957.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Huhn, Carolin. "CE in the Biotechnology & Pharmaceutical Industries—CE Pharm 2011." Analytical and Bioanalytical Chemistry 402, no. 4 (2011): 1405–6. http://dx.doi.org/10.1007/s00216-011-5618-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Augustine, Karen A. "Career paths for anatomists in the biotechnology and pharmaceutical industries." Anatomical Record 257, no. 6 (1999): 187–90. http://dx.doi.org/10.1002/(sici)1097-0185(19991215)257:6<187::aid-ar3>3.0.co;2-o.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Savitzky, Rodolfo J., and Klaus Möller. "Financial Leadership at Lonza." Controlling 33, no. 1 (2021): 75–78. http://dx.doi.org/10.15358/0935-0381-2021-1-75.

Full text
Abstract:
Lonza Group AG, based in Basel, Switzerland, manufactures active pharmaceutical ingredients, biotechnology products organic, fine chemicals and biocides. The Company offers custom chemical manufacturing and fermentation processing and manufactures its products for the life sciences, pharmaceuticals, food processing, and agricultural industries. Founded in 1897 Lonza has grown into a global chemicals and biotechnology business. The Company operates on 120 sites and offices in more than 35 countries with 15,500 full-time employees. In 2019, Lonza generated sales of CHF 5.9 bn with a CORE EBITDA
APA, Harvard, Vancouver, ISO, and other styles
9

Gray, M., and E. Parker. "Industrial Change and Regional Development: The Case of the US Biotechnology and Pharmaceutical Industries." Environment and Planning A: Economy and Space 30, no. 10 (1998): 1757–74. http://dx.doi.org/10.1068/a301757.

Full text
Abstract:
We examine the arguments surrounding the location and organization of innovative firms and examine the prospects for industry renewal and regional rejuvenation. We examine the effect of technological breakthroughs in the biotechnology industry on the organization and location of production with respect to mature and emergent regions. We find that, despite losing much of their preeminence in research and development, traditional firms in mature regions have managed to ‘capture’ a substantial amount of manufacturing and marketing. The drug-development experience, manufacturing capabilities, and
APA, Harvard, Vancouver, ISO, and other styles
10

Zeller, Christian. "The Pharma-biotech Complex and Interconnected Regional Innovation Arenas." Urban Studies 47, no. 13 (2010): 2867–94. http://dx.doi.org/10.1177/0042098010377370.

Full text
Abstract:
Large pharmaceutical firms, biotechnology firms, publicly funded research organisations and financial organisations which are inseparably connected and located in a few key regions have built a hierarchical pharma-biotech complex. It is argued that large corporations establish networks to access regionally concentrated knowledge bases. These networks consist of money flows, knowledge and personnel. By establishing such networks, large firms considerably shape and interconnect the development dynamics in the regions in which they have strategic assets. The paper reveals how the economic develop
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pharmaceutical and biotechnology industries"

1

Alimov, Azizjon. "Innovations, real options, risk and return : evidence from the pharmaceutical and biotechnology industries /." view abstract or download file of text, 2007. http://proquest.umi.com/pqdweb?did=1421619401&sid=1&Fmt=2&clientId=11238&RQT=309&VName=PQD.

Full text
Abstract:
Thesis (Ph. D.)--University of Oregon, 2007.<br>Typescript. Includes vita and abstract. Includes bibliographical references (leaves 109-114). Also available for download via the World Wide Web; free to University of Oregon users.
APA, Harvard, Vancouver, ISO, and other styles
2

Gretton, Linda Burak. "The rhetorical helix of the biotechnology and pharmaceutical industries strategies of transformation though definition, description and ingratiation /." Greensboro, N.C. : University of North Carolina at Greensboro, 2007. http://libres.uncg.edu/edocs/etd/1435/umi-uncg-1435.pdf.

Full text
Abstract:
Thesis (Ph.D.)--University of North Carolina at Greensboro, 2007.<br>Title from PDF t.p. (viewed Oct. 22, 2007). Directed by Nancy Myers; submitted to the Dept. of English. Includes bibliographical references (p. 209-228).
APA, Harvard, Vancouver, ISO, and other styles
3

Pooni, Gurkanwal Singh. "The creation and development of technology by MNEs within the chemical, pharmaceutical and biotechnology industries." Thesis, University of Reading, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.393242.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Houston, Chad Allen. "Biotechnology valuation an examination of the drug development pipeline and board of director composition /." View electronic thesis (PDF), 2009. http://dl.uncw.edu/etd/2009-3/r1/houstonc/chadhouston.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nel, Izak Bartholomeus Jacques. "The relationship between global pharmaceutical companies and the biotechnology industry in South Africa : implications for an emerging biotechnology industry in South Africa." Thesis, Stellenbosch : Stellenbosch University, 2003. http://hdl.handle.net/10019.1/53672.

Full text
Abstract:
Mini-study project (MBA)--University of Stellenbosch, 2003.<br>ENGLISH ABSTRACT: This report reviews the global and South African pharmaceutical and biotechnology industries and provides an overview of the changes taking place within these two industries. It highlights the impact this relationship will have on a developing South African biotechnology industry. Since the 1980s the pharmaceutical industry has experienced phenomenal growth in sales and profits. By the mid 1990s drug sales exceeded USD250 billion. Today the pharmaceutical industry is dominated by multi-national corporations
APA, Harvard, Vancouver, ISO, and other styles
6

Larsen, David Mark. "The discursive function and the embedding of capitalism : British state policy on the pharmaceuticals and biotechnology sector." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608970.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Guedri, Zied. "Performance variations among strategic group members in the pharmaceutical industry : an examination of individual sustainable growth capabilities, 1995-1997." Thesis, Connect to online version, 1998. http://0-wwwlib.umi.com.mercury.concordia.ca/cr/concordia/fullcit?pMQ39083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Boca, Madalina Brindusa. "Research into process validation in pharmaceutical companies, with specific reference to Roche, South Africa." Pretoria : [s.n.], 2009. http://upetd.up.ac.za/thesis/available/etd-10132009-181630/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fornander, Erik. "Ozone Treatment Targeting Pharmaceutical Residues : Validation and Process Control in a Wastewater Treatment Plant." Thesis, Linköpings universitet, Teknisk biologi, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-154012.

Full text
Abstract:
Major studies conducted in Europe and North America has concluded that the current processes in wastewater treatment plants insufficiently degrade micropollutants e.g. pharmaceutical residues. Several sorption and oxidation methods has therefore been investigated with the purpose of removing or degrading micropollutants in wastewater. The main purpose of this project was, firstly, to validate the results from a pilot study conducted by Tekniska verken i Linköping AB (2014) which investigated the use of ozone to degrade pharmaceutical residues. Secondly, to investigate and design a suitable pro
APA, Harvard, Vancouver, ISO, and other styles
10

Langer, Lynn Johnson. "How Scientist/Founders Lead Successful Biopharmaceutical Organizations: A Study of Three Companies." [Yellow Springs, Ohio] : Antioch University, 2008. http://www.ohiolink.edu/etd/view.cgi?acc_num=antioch1217337156.

Full text
Abstract:
Thesis (Ph.D.)--Antioch University, 2008.<br>"A dissertation submitted to the Ph.D. in Leadership & Change Program of Antioch University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2008."--from the title page. Title from PDF t.p. (viewed July 30, 2008). Advisor: Alan Guskin, Ph.D.. Keywords: biotechnology, biopharmaceutical, leadership, founder, success, management, case study Includes bibliographical references (p. 207-218).
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pharmaceutical and biotechnology industries"

1

Klefenz, Heinrich. Industrial pharmaceutical biotechnology. Wiley-VCH, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Industrial pharmaceutical biotechnology. Wiley-VCH, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, Lanju, ed. Nonclinical Statistics for Pharmaceutical and Biotechnology Industries. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23558-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Misch, Kelly, and William D. Martineau. Biotechnology pharmaceuticals. Freedonia Group, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Welch, Mary F., Esther K. Palevsky, Diana E. Kole, and Dawn J. Trebec. Biotechnology pharmaceuticals. Freedonia Group, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Friedman, Rebecca L., and William D. Martineau. Biotechnology in pharmaceuticals. Freedonia Group, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Llewellyn, Richard A. Biotechnology data base. SRI International, Health and Food Industries Center, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Business development for the biotechnology and pharmaceutical industry. Gower, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Medical biotechnology: Achievements, prospects and perceptions. United Nations University Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Burrill, G. Steven. Biotech 2003: Life sciences : revaluation and restructuring. Burrill & Co., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pharmaceutical and biotechnology industries"

1

Franssen, Maurice C. R., Manfred Kircher, and Roland Wohlgemuth. "Industrial Biotechnology in the Chemical and Pharmaceutical Industries." In Industrial Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2010. http://dx.doi.org/10.1002/9783527630233.ch9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kayser, Oliver, and Rainer H. Müller. "A Primer on Pharmaceutical Biotechnology and Industrial Applications." In Pharmaceutical Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2005. http://dx.doi.org/10.1002/3527602410.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Siahaan, Evi Amelia, Ratih Pangestuti, and Se-Kwon Kim. "Seaweeds: Valuable Ingredients for the Pharmaceutical Industries." In Grand Challenges in Marine Biotechnology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-69075-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kayser, Oliver, and Heribert Warzecha. "Pharmaceutical Biotechnology and Industrial Applications-Learning Lessons from Molecular Biology." In Pharmaceutical Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527632909.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Singu, Bhupender, and Uday Annapure. "Role of Enzymes in Pharmaceutical and Biotechnology Industries." In Enzymes in Food Technology. Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1933-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yang, P. W. "Controls and automation for biotechnology and pharmaceutical industries." In Handbook of Downstream Processing. Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-009-1563-3_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Thombre, Rebecca S., Vaishnavi S. Joshi, and Radhika S. Oke. "Halophiles: Pharmaceutical Potential and Biotechnological Applications." In Industrial Biotechnology. Apple Academic Press, 2017. http://dx.doi.org/10.1201/9781315366562-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhang, Lanju, and Cheng Su. "Introduction to Nonclinical Statistics for Pharmaceutical and Biotechnology Industries." In Nonclinical Statistics for Pharmaceutical and Biotechnology Industries. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23558-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kuhn, Max. "Quantitative-Structure Activity Relationship Modeling and Cheminformatics." In Nonclinical Statistics for Pharmaceutical and Biotechnology Industries. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23558-5_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bailey, Steven A., Dingzhou Li, and David M. Potter. "General Toxicology, Safety Pharmacology, Reproductive Toxicology, and Juvenile Toxicology Studies." In Nonclinical Statistics for Pharmaceutical and Biotechnology Industries. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23558-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharmaceutical and biotechnology industries"

1

Bhushan, Indu. "Efficient media for high production of microbial lipase from Bacillus subtilis (BSK-L) using response surface methodology for enantiopure synthesis of drug molecules." In 2nd International Scientific Conference "Plants and Microbes: the Future of Biotechnology". PLAMIC2020 Organizing committee, 2020. http://dx.doi.org/10.28983/plamic2020.044.

Full text
Abstract:
Lipases are a multipurpose enzyme that holds a significant position in industrial applications due to its ability to catalyse a large number of reactions such as hydrolysis, esterification, interesterification, transesterification which makes it a potential candidate. It is also used for the separation of chiral drugs from the racemic mixture and this property of lipase is considered very important in pharmaceutical industries for the synthesis of enantiopure bioactive molecules. Assuming the tremendous importance of lipases, as stereoselective biocatalysts, in pharmaceuticals and various othe
APA, Harvard, Vancouver, ISO, and other styles
2

MATOS, Murilo Montanari de, and Sérgio Robles Reis de QUEIROZ. "Technical Change and the Incorporation of Biotechnology in the Pharmaceutical Industry." In II Encontro Nacional de Economia Industrial e Inovação. Editora Blucher, 2017. http://dx.doi.org/10.5151/enei2017-06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gutierrez, Mauricio R., and Kamal Youcef-Toumi. "Programmable Separation for Biologically Active Molecules." In ASME 2006 International Mechanical Engineering Congress and Exposition. ASMEDC, 2006. http://dx.doi.org/10.1115/imece2006-14141.

Full text
Abstract:
Separation of biologically active molecules (BAMs) is a problem for the pharmaceutical and biotechnology industries. Current technologies addressing this problem require too many techniques, toxic additives, and time to filter the desired materials. As a result, a new technology is needed. The objective of this work is to contribute to the development of a device that can separate 0.5 nm to 500 nm sized BAMs. A diaphragm valve is proposed that can control a gap created by two parallel flat surfaces. Position control is achieved by means of a piezoelectric actuator and a capacitive sensor. Modu
APA, Harvard, Vancouver, ISO, and other styles
4

Ziu, Christopher G., and Yaofeng Chen. "Use of Conical-Shaped Anchors to Reduce Stresses in Thermoplastic Dual Containment Piping Systems." In ASME 2005 Pressure Vessels and Piping Conference. ASMEDC, 2005. http://dx.doi.org/10.1115/pvp2005-71639.

Full text
Abstract:
Double containment piping systems are used extensively for handling the conveyance of critical waste systems in industries such as pharmaceuticals and biotechnology manufacturing and research. Often, these services involve the conveyance of critical fluids at elevated temperatures. An example would be in the discharge and transport of spent fermentation by-products in the biotech industry, where the vessel contents are sanitized by the addition of water at up to 210°F and then discharged through double containment piping. Materials of construction used in such systems include thermoplastic, RT
APA, Harvard, Vancouver, ISO, and other styles
5

Sumitomo, Takashi, Junichiro Fukutomi, Toru Shigemitsu, Naoki Ishida, and Yoshio Yoshimura. "Study of Internal Flow and Emulsification Process in a Homogenizer." In ASME 2009 Fluids Engineering Division Summer Meeting. ASMEDC, 2009. http://dx.doi.org/10.1115/fedsm2009-78335.

Full text
Abstract:
The pressure homogenizer is extensively used to emulsify, disperse the products in various industrial fields including: food, chemical, pharmaceutical and biotechnology. The homogenizer basically consists of a high-pressure plunger pump usually with triple plungers to minimize pressure fluctuations and a homogenizing valve with a narrow gap. The homogenizing valve consists of a valve, valve seat and impact ring. The homogenizer exerts effects, such as a shear, an impingement, and a cavitation to fluid momentarily. The relatively large polydisperse oil globules of a coarse oil-in-water emulsion
APA, Harvard, Vancouver, ISO, and other styles
6

Jiyong Kim, Hyerim Kim, and Il Moon. "A novel scheduling model for pharmaceutical industries using heuristic techniques." In 2008 International Conference on Control, Automation and Systems (ICCAS). IEEE, 2008. http://dx.doi.org/10.1109/iccas.2008.4694464.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gruenwald, G., and T. Lee. "164. Glutaraldehyde Exposures after Disinfectant Fogging in Pharmaceutical Aseptic Rooms: Evaluation and Control." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2764825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rothney, M. T., and K. R. Schmerber. "467. A Comprehensive Pharmaceutical Industry Occupational Exosure Database Designed for Plant-Specific and Corporate Risk Analysis." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2765154.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Harbell, J., R. Curren, H. Raabe, and R. Sussman. "379. Predicting the Ocular Irritancy of Chemical Intermediates for the Pharmaceutical Industry Using Non-Whole Animal Methods." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2765057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Charron, K., M. Puskar, and S. Levine. "207. Field Validation of Passive Monitors for the Determination of Employee Exposures to Methylene Chloride in Pharmaceutical Production Facilities." In AIHce 1996 - Health Care Industries Papers. AIHA, 1999. http://dx.doi.org/10.3320/1.2764872.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Pharmaceutical and biotechnology industries"

1

Greene, Anne, Kelly Waldron, and Nuala Calnan. Quality Risk Management: State of the Industry—Part 1. Has the Industry Realized the Full Value of ICH Q9? Institute of Validation Technology, 2014. http://dx.doi.org/10.1080/21507090.ar1152014agkwnc-qrmsoi.

Full text
Abstract:
This paper summarizes research designed to characterize the current state of pharmaceutical and biotechnology industries with respect to the adoption of Quality Risk Management as per ICH Q9. The research supports the hypotheses that the full value of QRM with respect to product quality and patient safety has not yet been realized. In addition, industry appears to be lagging behind regulatory expectations with respect to QRM maturity, indicating that current approaches to QRM require significant improvement.
APA, Harvard, Vancouver, ISO, and other styles
2

Danzon, Patricia, Andrew Epstein, and Sean Nicholson. Mergers and Acquisitions in the Pharmaceutical and Biotech Industries. National Bureau of Economic Research, 2004. http://dx.doi.org/10.3386/w10536.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Danzon, Patricia, Sean Nicholson, and Nuno Sousa Pereira. Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances. National Bureau of Economic Research, 2003. http://dx.doi.org/10.3386/w9615.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Higgins, Matthew, Paula Stephan, and Jerry Thursby. Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology. National Bureau of Economic Research, 2008. http://dx.doi.org/10.3386/w14602.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Khasaeva, Fatima, Igor Parshikov, and Evgeny Zaraisky. Degradation of 2,6-dimethylpyridine by Arthrobacter crystallopoietes. Intellectual Archive, 2020. http://dx.doi.org/10.32370/iaj.2463.

Full text
Abstract:
Degradation of pyridines in waste water is an important issue for chemical and pharmaceutical industries. The biodegradation of 2,6-dimethylpyridine was investigated by the bacterium Arthrobacter crystallopoietes KM-4, which resulted in the formation of three metabolites: 2,6-dimethylpyridin-3-ol, 2,6-dimethylpyridin- 3,4-diol, and 2,4-dioxopentanoic acid.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pharmaceutical and biotechnology industries' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography